x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Proactive - Interviews for investors

Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.

business investing

All Episodes

00:03:20

ARway.ai announces another key paid partnership with...

Proactive - Interviews for investors ·

2024/03/19

ARway.ai Chief Executive Officer Evan Gappelberg joined Steve Darling from Proactive to announce a significant partnership with EWROS, a prominent developer of automation systems software based in Turkey. ARway.ai has entered into a paid partner deal with EWROS, marking a strategic move in the company's expansion efforts. EWROS is recognized as a leading provider of automation solutions in the region, making it an ideal partner for ARway.ai's innovative AR technology. Under the partnership, EWROS

en

00:03:08

Abitibi Metals announces company is adding 3rd drill...

Proactive - Interviews for investors ·

2024/03/19

Abitibi Metals Corp CEO Jonathon Deluce joined Steve Darling from Proactive to share exciting developments regarding the company's ongoing maiden drill program at the B26 Polymetallic Deposit. Deluce revealed that Abitibi Metals Corp has secured a third drill rig to bolster its exploration efforts significantly. This additional drill rig is slated to arrive promptly, aligning seamlessly with the company's ambitious timeline. Deluce emphasized that this strategic move will ensure that Abitibi Metals

en

00:03:36

First Phosphate announces strong initial assay result...

Proactive - Interviews for investors ·

2024/03/19

First Phosphate Corp CEO John Passalacqua and Chief Geologist Gilles Laverdiere joined Steve Darling from Proactive to shared the initial assay results from the ongoing drill program at the Bégin-Lamarche Project in Quebec. Phosphate Mountain Zone: Nine drill holes have been completed in this zone, intersecting high apatite-bearing peridotite visually containing from 30% to 80% apatite over widths of up to 43 metres. In the Northern Zone drill hole BL-24-25 intersected 9.89% P2O5 (phosphate) over

en

00:07:22

Cordiant Digital Infrastructure marks three years of...

Proactive - Interviews for investors ·

2024/03/19

Cordiant Digital Infrastructure Ltd (LSE:CORD) Chairman of Digital Infrastructure Steven Marshall and Chief Financial Officer Mark Tiner joined Steve Darling from Proactive to provide some insight on the company’s three-year anniversary since listing on the London Stock Market. The company has made significant strides, raising just shy of a billion dollars from investors. The company has expanded its portfolio by acquiring substantial assets in the digital infrastructure sector, including tower

en

00:08:44

Team Internet celebrates milestone year with strong...

Proactive - Interviews for investors ·

2024/03/19

Team Internet Group chief financial officer Billy Green highlights the company's significant achievements in 2023, marking it as a milestone year. Green told Proactive's Stephen Gunnion the firm reported strong growth in revenue and profit across all metrics, with an operating profit of £42.3 million, a 26% increase over 2022. Notably, Team Internet achieved a profit after tax of £24.3 million, a remarkable turnaround from a £2.1 million loss the previous year. This success reflects the company's

en

00:01:24

FTSE starts flat, Unilever jumps on ice cream...

Proactive - Interviews for investors ·

2024/03/19

The FTSE 100 has opened flat, with the largest gain coming from multinational consumer goods heavyweight Unilever. The company lifted more than 5% in early trading after launching plans to sack 7,500 workers as part of an overhaul of its ice cream business. Over in the pharmaceutical industry, AstraZeneca revealed its intention to buy oncology group Fusion for £1.9 billion, a nearly 125% premium to the US-listed group’s closing price on Monday. Close Brothers soared close to 10% after it unveiled

en

00:05:13

Recce Pharmaceuticals hits major milestone in R327...

Proactive - Interviews for investors ·

2024/03/19

Recce Pharmaceuticals Ltd (ASX:RCE) CEO James Graham joins Proactive to talk through significant progress in the journey of RECCE® 327 (R327) for treating urinary tract infections (UTI) and urosepsis. The company has completed dosing in its Phase 1/2 clinical trial, which focused on evaluating R327's safety and pharmacokinetics at fast infusion rates. Following the completion of this phase of the trial, an independent safety committee will assess the data. This analysis is crucial for advancing to

en

00:14:24

Chariot Corporation expands Wyoming lithium ventures

Proactive - Interviews for investors ·

2024/03/19

Managing director of Chariot Corp Ltd (ASX:CC9) Shanthar Pathmanathan joins Jonathan Jackson in the Proactive studio to discuss the company's ventures in the Wyoming lithium scene. With the largest landholding in the region, Pathmanathan discusses the appeal of Wyoming as a lithium hotspot and the strategic move to increase the company's ownership interests in its Wyoming portfolio to 93.9%. Exploring the recent expansion at the Black Mountain project, he highlights a significant increase in tenure

en

00:03:48

Elixir Energy advances gas projects in Queensland and...

Proactive - Interviews for investors ·

2024/03/19

Elixir Energy Ltd (ASX:EXR) managing director Neil Young sits down with Proactive’s Jonathan Jackson to discuss the significant strides the company is making in de-risking its gas projects in Queensland and Mongolia. Its Daydream-2 well at the Grandis Project in Queensland is set to undergo rigorous stimulation and flow testing activities, managed by Halliburton, through mid-year. This activity in the Taroom Trough is generating increasing interest in the gas sector. In parallel, Elixir continues to

en

00:07:00

Celsius Resources secures key mining permit for MCB...

Proactive - Interviews for investors ·

2024/03/19

Celsius Resources Ltd (ASX:CLA, AIM:CLA) managing director Peter Hume tells Proactive's Stephen Gunnion the company has achieved a significant milestone by being granted a mining permit for the MCB project, marking a pivotal transition from exploration to mineral resource development. This permit, valid for 25 years and renewable for a further 25, encompasses extensive exploration and development rights within the project area. The MCB project is located in the Philippines and is known for its

en

00:03:15

Galileo Mining identifies drill targets ahead of...

Proactive - Interviews for investors ·

2024/03/19

As it moves a step closer to a new drilling season, Galileo Mining Ltd (ASX:GAL) managing director Brad Underwood sits down with Jonathan Jackson to discuss the program and identified targets. The targets, identified through modelling of induced polarisation (IP) survey data, revealed strong chargeable anomalies near the notable Callisto nickel-palladium deposit. With drilling planned to start in late April, Galileo will test these anomalies for economic mineralisation, focusing on disseminated

en

00:03:44

Alkane Resources nears Kaiser resource upgrade with...

Proactive - Interviews for investors ·

2024/03/19

On the brink of significantly upgrading the mineral resource estimate for its Kaiser deposit in the Northern Molong Porphyry Project in New South Wales, Alkane Resources Ltd (ASX:ALK) managing director Nic Earner takes Proactive’s Jonathan Jackson through the latest drilling results. Alkane has delivered the highest gold grades observed to date at the site. Earner highlights the remarkable findings from the final 12,000-metre round of drilling, which confirmed the presence of high-grade sections

en

00:07:52

OzAurum to start drilling at Boca Rica Lithium Project

Proactive - Interviews for investors ·

2024/03/19

OzAurum Resources Ltd (ASX:OZM) CEO and managing director Andrew Pumphrey sits down with Proactive’s Jonathan Jackson to discuss an upcoming drilling program at Boca Rica Lithium Project in Brazil, following the identification of a spodumene zone. The company plans to start drilling in the next three to four weeks, contingent on weather and the receipt of environmental permits. Pumphrey emphasised the project's potential for a major lithium discovery, highlighting the strategic scale of the site and

en

00:07:06

Ionic Rare Earths on track to be first ASX producer...

Proactive - Interviews for investors ·

2024/03/18

Ionic Rare Earths Ltd (ASX:IXR) managing director Tim Harrison joins Jonathan Jackson in the Proactive studio as the company sets itself to become the first ASX-listed company to produce magnet rare earth oxides (REOs) from recycled wind turbines. Harrison highlights the company's journey towards becoming a major producer of recycled separated magnet REO, a milestone that positions IonicRE as a frontrunner in establishing a sustainable supply chain outside China. IonicRE's innovative approach

en

00:05:25

Xeris Biopharma Surpasses 2023 Expectations with...

Proactive - Interviews for investors ·

2024/03/18

Xeris Biopharma CEO Paul Edick joined Steve Darling from Proactive to share news the company had a successful 2023, with a final tally of 164 million USD, which is at the upper end of their forecast. The company concluded the year with 72 million USD in cash, surpassing their initial projections and achieving cash positivity in Q4. Xeris Biopharma, described as a multifaceted entity with three commercial assets growing in 2023, also benefits from proprietary technologies and has partnerships with

en

00:04:49

Lexaria Bioscience Revolutionizes Drug Delivery with...

Proactive - Interviews for investors ·

2024/03/18

Lexaria BioScience CEO Chris Bunka joined Steve Darling from Proactive to share significant updates regarding its focus on DehydraTECH, a patented drug delivery formulation and processing platform technology aimed at improving the oral delivery of active pharmaceutical ingredients. Lexaria BioScience has initiated its second DehydraTECH-powered glucagon-like peptide 1 (GLP-1) human pilot study. This randomized, crossover, placebo-controlled investigation will compare three dose formulations, each

en

00:11:52

HANetf founder and co-CEO discusses shift to active...

Proactive - Interviews for investors ·

2024/03/18

HANetf founder and co-CEO Hector McNeil tells Proactive's Stephen Gunnion about shifting trends in the exchange-traded fund (ETF) market in the United States, indicating a big move towards active management within ETFs. Despite the European market lagging behind the US by three to five years, with a significant gap in market size—$2 trillion in Europe versus $8 trillion in the US—there is a notable increase in the proportion of active ETFs. In the US, approximately 75% of new ETFs are active,

en

00:03:40

Awale Resources reports more significant assay...

Proactive - Interviews for investors ·

2024/03/18

Awale Resources Ltd (TSX-V:ARIC) CEO Andrew Chubb shares positive assay results from follow-up drilling at the new gold-copper discovery at the BBM Target within the Odienné Project in Côte d'Ivoire with Proactive's Stephen Gunnion. Initially discovered in January with four initial drill holes spaced 500 metres apart, subsequent drilling improved results, tracking down a plunge with broader intercepts. The most notable result was 75 metres at 2.4 grams per tonne equivalent, among other similarly

en

00:10:03

Immunic CMO discusses complexities of multiple...

Proactive - Interviews for investors ·

2024/03/18

Immunic Inc (NASDAQ:IMUX) Chief Medical Officer Dr Andreas Muehler discusses the complexities of multiple sclerosis (MS) during an interview with Proactive's Stephen Gunnion to mark MS Awareness Month, highlighting the disease's impact, development, and the unmet medical needs of patients. MS, a lifelong autoimmune disease more prevalent in women than men, begins typically in early adulthood. It manifests in various forms, starting with relapsing-remitting MS, characterized by relapses and MRI

en

00:04:26

Valeo Pharma Q1 numbers shows asthma product revenues...

Proactive - Interviews for investors ·

2024/03/18

Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to discuss the company's financial results for the first quarter ended January 31, 2024. Valeo Pharma reported revenues of $13.5 million in Q1-24, compared to $13.1 million in Q1-23 and $13.1 million in Q4-23, representing a 3% increase. The company recorded an adjusted gross profit of $3.9 million in Q1-24, similar to the figure in Q1-23, and a significant increase from $2.1 million in Q4-23, marking an 81% rise. Saviuk told

en

4,533 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...